Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-12 12:31 pm Purchase |
2020-12-31 | 13G | Xeris Biopharma Holdings, Inc. XERS |
Flynn James E | 5,882,353 4.985% |
3,299,062 (+127.71%) |
Filing History |
| 2021-02-12 12:31 pm Sale |
2020-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
Flynn James E | 2,721,203 6.160% |
-1,568,088 (-36.56%) |
Filing History |
| 2021-02-12 12:30 pm Purchase |
2020-12-31 | 13G | Puma Biotechnology, Inc. PBYI |
Flynn James E | 3,959,741 9.960% |
1,681,588 (+73.81%) |
Filing History |
| 2021-02-12 12:30 pm Sale |
2020-12-31 | 13G | Orchard Therapeutics plc ORTX |
Flynn James E | 694,942 7.110% |
-191,283 (-21.58%) |
Filing History |
| 2021-02-12 12:29 pm Sale |
2020-12-31 | 13G | Meridian Bioscience, Inc. VIVO |
Flynn James E | 2,161,000 5.010% |
-208,166 (-8.79%) |
Filing History |
| 2021-02-12 12:28 pm Purchase |
2020-12-31 | 13G | Lumos Pharma, Inc. LUMO |
Flynn James E | 936,291 11.280% |
936,291 (New Position) |
Filing History |
| 2021-02-12 12:28 pm Unchanged |
2020-12-31 | 13G | IVERIC bio, Inc. ISEE |
Flynn James E | 5,767,409 6.440% |
0 (Unchanged) |
Filing History |
| 2021-02-12 12:27 pm Sale |
2020-12-31 | 13G | Brookdale Senior Living Inc. BKD |
Flynn James E | 11,023,465 6.010% |
-6,268,468 (-36.25%) |
Filing History |
| 2021-02-12 12:26 pm Purchase |
2020-12-31 | 13G | BioDelivery Sciences International, Inc. BDSI |
Flynn James E | 9,530,000 9.430% |
2,984,500 (+45.60%) |
Filing History |
| 2021-02-09 2:21 pm Purchase |
2021-02-09 | 13G | Terns Pharmaceuticals, Inc. TERN |
Flynn James E | 2,382,033 9.940% |
2,382,033 (New Position) |
Filing History |
| 2021-02-05 12:41 pm Purchase |
2021-01-29 | 13G | Profound Medical Corp. PROF |
Flynn James E | 1,040,421 5.300% |
1,040,421 (New Position) |
Filing History |
| 2021-02-03 5:22 pm Purchase |
2021-02-01 | 13G | Ignyte Acquisition Corp. IGNYU |
Flynn James E | 725,000 11.420% |
725,000 (New Position) |
Filing History |
| 2021-01-08 3:32 pm Unchanged |
2021-01-05 | 13D | Protara Therapeutics, Inc. TARA |
Flynn James E | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2020-12-17 10:56 am Purchase |
2020-12-11 | 13G | Delcath Systems, Inc. DCTH |
Flynn James E | 500,000 8.750% |
500,000 (New Position) |
Filing History |
| 2020-12-08 4:12 pm Purchase |
2020-11-23 | 13G | CONSONANCE-HFW ACQUISITION COR CHFWU |
Flynn James E | 500,000 5.950% |
500,000 (New Position) |
Filing History |
| 2020-11-24 5:18 pm Purchase |
2020-11-16 | 13G | Itamar Medical Ltd. ITMR |
Flynn James E | 23,814,090 5.610% |
23,814,090 (New Position) |
Filing History |
| 2020-11-20 3:59 pm Unchanged |
2020-11-12 | 13D | Graybug Vision, Inc. GRAY |
Flynn James E | 377,265 25.180% |
0 (Unchanged) |
Filing History |
| 2020-10-30 11:42 am Purchase |
2020-10-20 | 13G | TURMERIC ACQUISITION CORP UNIT TMPMU |
Flynn James E | 750,000 7.360% |
750,000 (New Position) |
Filing History |
| 2020-10-30 11:39 am Purchase |
2020-10-27 | 13G | Eucrates Biomedical Acquisition Corp. EUCRU |
Flynn James E | 1,000,000 7.780% |
1,000,000 (New Position) |
Filing History |
| 2020-10-26 5:08 pm Purchase |
2020-10-16 | 13G | Meridian Bioscience, Inc. VIVO |
Flynn James E | 2,369,166 5.530% |
2,369,166 (New Position) |
Filing History |